GLP-1, beyond its insulinotropic function, also aids in reducing appetite, slowing gastrointestinal motility, and promoting beta cell proliferation, which is beneficial in treating obesity and T2DM [25]. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.